MAISITA for Pharma
.svg)
.svg)
Native corn starches for filling, carrying and process handling in solid dosage forms
MAISITA is a range of native corn starches for pharmaceutical applications where filling performance, powder handling and formulation compatibility need to work together reliably. Based on corn raw material, the range supports solid dosage concepts such as tablets, pills and dragées in formulations where a starch-based excipient is required for bulk, carrier function and controlled processing behavior.
Native corn starch is used in pharmaceutical systems for its practical functionality in dry blends and solid formulations. It can contribute to fill volume, support ingredient distribution and fit into production processes where consistent raw material behavior and dependable handling are important.
Key benefits
- Reliable filler and carrier functionality supports formulation design in tablets, pills and dragées.
- Good powder handling can contribute to stable processing and practical integration into dry blending and dosing steps.
- Native corn starch offers broad excipient relevance where straightforward functionality and established starch performance are required.
- Corn-based origin supports use in formulations where material selection, handling behavior and application fit need to be balanced carefully.
MAISITA can be used in tablet formulations where fill volume, powder distribution and practical process handling matter. Its native starch functionality supports concepts that require reliable excipient behavior within the broader formulation and compression process.
In pill applications, MAISITA supports formulations where carrier performance and controlled handling during blending and shaping are important. It can contribute to process consistency in systems that rely on balanced bulk properties and dependable dry-material behavior.
For dragée applications, MAISITA can be considered where filler function, carrier role and formulation compatibility need to align with coating and processing requirements. Its use is relevant in systems where stable handling and defined excipient performance are necessary across production steps.
Product range
Formulation insights
What makes native corn starch relevant in pharmaceutical solid dosage formulations
In formulation, MAISITA contributes the practical functionality of native corn starch through bulk contribution, carrier performance and dry blend integration. This makes it relevant in pharmaceutical systems where excipient functionality must support both the processing route and the intended dosage form.
Performance in use always depends on the surrounding formulation. Particle size distribution, moisture sensitivity, active ingredient characteristics, blend uniformity, compression parameters and downstream coating conditions all influence how the starch performs in the final application. This is especially important in tablets, pills and dragées, where excipient behavior affects both manufacturability and product consistency.
The most suitable starch grade should therefore be assessed in relation to the complete formulation and process conditions. Fill behavior, compatibility with other excipients, moisture profile and production requirements should be evaluated together rather than considering the starch component in isolation.
Packaging options
We offer a broad range of products and packaging solutions globally. Availability may vary by market due to local requirements. Please contact us to learn more about the options available in your region.